Abstract. We tested serum samples collected in 1997 and 1998 from a cohort of 204 injection drug users (IDUs) recruited from Central and East Harlem, New York City, New York, for antibodies reactive with seven rickettsial or Bartonella spp. antigens. Rodent-associated Bartonella elizabethae and Rickettsia akari were the primary etiologic agents of interest. The testing panel also included Bartonella henselae, Bartonella quintana, Rickettsia prowazekii, Rickettsia rickettsii, and Rickettsia typhi. The highest prevalence of seroreactive serum samples (46%) was found with B. elizabethae antigens; 10% of the samples reacted with B. henselae antigens, while 2% reacted with B. quintana antigens. Reactivity to the latter two antigens was likely due to cross-reactivity with B. elizabethae antigens in most instances. Among the spotted fever group rickettsiae, 18 (9%) samples reacted with R. akari, including 10 samples (5%) that also reacted with R. rickettsii. Cross-adsorption studies demonstrated that most of the spotted fever group rickettsiae antibodies were due to R. akari infections. Among the typhus group rickettsiae, 5 samples reacted weakly to R. prowazekii antigens, and no samples reacted with R. typhi antigens. These findings suggest that Harlem IDUs are commonly exposed to two rodent-associated zoonotic agents. Further study of IDU populations may help elucidate transmission cycles of these agents in inner cities where higher levels of transmission occur.
INTRODUCTION
Injection drug users (IDUs) are at an increased risk for exposure to blood-borne pathogens because they share injection equipment. Human immunodeficiency virus (HIV), 1 hepatitis B virus (HBV), 2 and hepatitis C virus (HCV) 3 are examples of pathogens that spread easily and rapidly through IDU populations. Behavioral and immunological characteristics associated with drug use also predispose IDUs to increased prevalence of diseases that are not blood-borne, such as Mycobacterium tuberculosis 4 and antibiotic-resistant Staphylococcus aureus. 5 Recent studies suggested that inner-city IDUs are also exposed to zoonotic pathogens that have common urban mammals as their primary reservoir. One-third of a cohort of 631 IDUs in inner-city Baltimore, Maryland, had antibodies to Bartonella elizabethae, 6 a cause of endocarditis. 7 This bacterium has a mammalian reservoir that includes the Norway rat (Rattus norvegicus), 8 a rodent of Old World origin that is now a common inhabitant of cities. In the same cohort, 16% of the IDUs had antibodies to a Rickettsia species that was shown through cross-adsorption studies to be Rickettsia akari, the agent of rickettsialpox. 9 This organism is primarily maintained by another rodent species introduced from the Old World, the house mouse (Mus musculus), which also enjoys a near-cosmopolitan distribution. Because of these reports of rickettsial and Bartonella infections in IDUs, we tested a cohort of IDUs from Central and East Harlem for further evidence of widespread infection with these agents.
MATERIALS AND METHODS
Study population and collection of samples. The serum samples tested in this study consisted of a convenience sample from the Collaborative Injection Drug Users Studies II (CIDUS II) study, which was conducted by the Center for Urban Epidemiologic Studies (CUES), New York Academy of Medicine and the Centers for Disease Control and Prevention (CDC). Central and East Harlem, New York City, New York, was one of six sites selected for the CIDUS II study. The overall focus of the CIDUS II study was concerned with an individual's initiation into intravenous drug use, needle use and acquisition, and sexual behaviors.
To be eligible for the study, participants must have reported injection drug use within the previous 6 months and been 18 to 29 years of age. Recruitment for the study took place in Central Harlem (predominantly an African-American population) and in East Harlem (predominantly a Latino population). Community-based outreach techniques were used to recruit young IDUs. First, using ethnographic techniques, Central and East Harlem and the Lower East Side were mapped to determine specific areas where young injectors congregated. Recruiters were then sent to these areas where they approached young persons, engaged them in conversation, formally assessed eligibility by asking structured questions, and asked those who were eligible to participate in the study. If persons agreed to participate in the study, they were escorted to the study office to receive information about the study and provide informed consent. They were also given US$25 after completion of an interview.
Participants were administered a detailed questionnaire by trained interviewers. Questions were asked about sociodemographics and IDU initiation behaviors as well as drug use and sexual behaviors during the previous 6 months. Blood was drawn by venipuncture and allowed to clot. Serum was tested for antibodies to HIV, HBV, and HCV; remaining serum was retained for future serologic studies. All participants received pre-and post-test counseling (when returning for results) and referral for health care and drug treatment when appropriate. For this analysis and laboratory testing, stored serum was used. Samples tested in the study were stripped of all personal identification and blinded by CUES HIV, HBV, and HCV testing. Sera were analyzed for HIV-1 antibodies by standard techniques at local laboratories. Specimens repeatedly reactive on an enzyme-linked immunosorbent assay (ELISA) were confirmed by Western blot analysis.
Blood specimens were sent to the CDC to test for serologic markers for HBV and HCV. Samples were also tested for antibody to HCV (Abbott HCV EIA 2.0, Abbott Laboratories, Chicago, IL). A sample of 100 specimens repeatedly reactive for HCV based on EIA received supplemental testing and were all found to be positive. Because of the high positive predictive value of repeat reactive EIA testing in this population, no further supplemental HCV testing was performed. Samples were tested for antibody to HBV core antigen (anti-HBc) by using standard techniques (CORAB, Abbott Laboratories).
Indirect immunofluorescence antibody (IFA) test. Blinded serum samples were tested against seven antigens: Bartonella elizabethae, B. henselae, B. quintana, Rickettsia akari, R. prowazekii, R. rickettsii, and R. typhi. Samples were first screened at a 1/16 dilution using a mixture (equal proportions by volume) 10 of the different antigens according to the three antigenic serogroups. Separate sets of screening slides were prepared for the three Bartonella species, the spotted fever group rickettsiae (R. akari and R. rickettsii), and the typhus group rickettsiae (R. prowazekii and R. typhi).
Serial two-fold dilutions of samples that reacted strongly at the 1/16 screening dilution were titrated to endpoint using slides prepared separately for each antigen. The IFA was conducted as described, 9 except that conjugate specific for the gamma chain of human immunoglobulin G (Kirkegaard and Perry, Gaithersburg, MD) was used at a 1/150 dilution in all tests. All titers were expressed as the reciprocal of the highest dilution that was reactive to the respective agents. A titer of Ն 64 was considered to be positive for all antigens. Geometric mean titers (GMT) were calculated for each antigen using all positively reacting samples.
Cross-adsorption studies. For confirmation of rickettsialpox, we used the cross-adsorption technique described by Brettman and others. 11 The six samples that had the highest (Ն 512) titers to R. akari were selected for adsorption studies. Serum samples were adsorbed at a 1/16 dilution (prepared from a master 1/8 dilution) with yolk sac-derived R. akari and R. rickettsii antigens for 5.5 hr at 37ЊC. 12 Samples were gently swirled every hour.
Statistical analyses. Statistical analyses were conducted using SPSS 13 and Epi-Info 14 software. For all tests, a P value of Յ 0.05 was considered significant. Age was stripped as an identifying variable in the blinding process. Univariate analyses were used to relate reactivity with individual antigens observed in the present study to serologic results obtained previously for antibodies to HIV, HBV, and HCV. Other variables assessed included sex of participant, prior history of Chlamydia, homelessness in the previous 6 months (yes/no), presently having a regular place to stay (yes/no), sexual orientation (heterosexual versus gay or bisexual), and primary location for sleeping (on the streets, in abandoned buildings, and these locations combined versus other areas with presumably less rodent exposure). Drug userelated variables included use of crack cocaine in the previous 6 months (never, ever), frequency of using previouslyused needles to inject during the last 6 months (never, ever), primary location for injection of drugs (crack houses, abandoned buildings, or on the street, and these locations combined versus other areas with presumably less rodent exposure), and alcohol use (regular drinker versus nondrinker or not a regular drinker).
RESULTS

Demographic characteristics of the study population.
The study population was predominantly male (72%) and of Hispanic origin (76%). The majority of the participants did not complete high school (56%) ( Table 1) . Although individual ages were not made available to us, all study participants were between 18 and 29 years of age. No significant differences in prevalence of antibodies to Bartonella or Rickettsia antigens were found for any of the demographic categories.
Blood-borne infections normally associated with injection drug use were common in this group. The prevalence of antibodies to HIV was 9.4%, while 32.6% were seropositive for HBV (core antigen) and 50.5% were seropositive for HCV. Previous Chlamydia infections were reported by 8 individuals (3.9%) in the cohort.
Reactivity to Rickettsia and Bartonella antigens. Positive reactions to 6 of the 7 antigens were noted among the 204 Harlem IDUs. Ninety-seven samples (47.5%) reacted with one or more Bartonella antigens, while 21 samples (10.3%) reacted with one or more Rickettsia antigens ( Table  2 ). The number of seropositive samples, their GMTs, and range of titers for each antigen is presented in Table 2 . Table 2 ). Cross-adsorption studies on the six samples with the highest titers to R. akari demonstrated a characteristic elimination of titers to R. akari when adsorbed with R. akari and partial reduction of titers when adsorbed with R. rickettsii (Table 3 ). This pattern of one-way diminishment is considered definitive for a serologic diagnosis of rickettsialpox. 11 Further analyses were conducted only for individuals reactive to B. elizabethae and R. akari antigens. A primary site of injecting drugs on the street was associated with being seropositive for B. elizabethae (odds ratio 
DISCUSSION
The findings of this study of East and Central Harlem IDUs were consistent with results from earlier studies of IDUs in inner-city Baltimore. A high percentage (46%) of this cohort of IDUs had antibodies to B. elizabethae, as did 33% of 630 IDUs from Baltimore. 6 The prevalence of antibodies to B. elizabethae in non-IDU populations is variable. Twenty-one percent of clinical samples submitted to CDC for cat scratch disease testing had antibodies to B. elizabethae, although most of these also had higher titers to B. henselae and B. quintana. 15 In Seattle, 15% of blood donors reacted positively to B. elizabethae. 6 Absence of overt morbidity in excess of that normally seen in an IDU population suggests that infections with B. elizabethae or antigenically related organisms are asymptomatic or mild. Alternatively, since infections may have occurred several months prior to enrollment in the study, it is possible that acute disease simply goes unheeded or undiagnosed in this population. Because B. elizabethae has been recognized as a human pathogen only since 1993, and only a single definite case has been identified, 7 the range of clinical signs and symptoms is unknown. The only human isolate was made from a patient with endocarditis, 7 and serologic evidence suggests that infection with B. elizabethae may also be associated with Leber's neuroretinitis. 16 This high antibody prevalence suggests that this or related organisms are ubiquitous in the inner-city IDU environment, and that exposure is commonplace. The mechanisms by which Bartonella infections are acquired by IDUs is unknown. However, likely modes would include direct contact with bacteria shed from rodents and vector transmission by rodent ectoparasites.
The high prevalence of antibodies in IDUs could also be associated with or augmented by blood-borne transmission of bacteria through the use of shared injection equipment by bacteremic IDUs. Several Bartonella species cause prolonged, chronic, or relapsing bacteremia in mammalian hosts. [17] [18] [19] [20] The level of bacteremia that B. elizabethae establishes in a human or the dose required for establishing parenteral infection is not known. Although the prevalence of needle sharing in this population during the previous 6 months was low for an IDU population (26%), some Bartonella infections might have been acquired by this mechanism. Rather, the low prevalence of needle sharing in this cohort suggests that most infections are rodent-associated. Attempts by health care providers to isolate Bartonella from IDUs or other high-risk groups should be undertaken to verify that infection with B. elizabethae is occurring and the antibody is specific to this organism.
Serologic cross-reactions occur among the 3 species of Bartonella, 15 which likely explains the lower titers to B. henselae and B. quintana in multiply reactive serum samples where the highest titers were to B. elizabethae. Serologic cross-reactions with other bacteria could also contribute to the high seroprevalence to Bartonella in this population. Antibodies to Bartonella species and Chlamydia pneumoniae may be cross-reactive, 21 as Chlamydia infections are associated with IDUs. 22 However, in the present study, there was no significant association between the presence of Bartonella antibodies and reported Chlamydia infections (OR ϭ 2.03 [95% CI 0.41-11.05, P ϭ 0.33). It is also possible that some of the reactivity with B. elizabethae antigens may be falsepositive reactions as reported with other agents associated with abnormalities or impairments in the immune system because of chronic substance abuse. 23 The presence of antibodies to B. elizabethae was associated with persons who inject drugs on the streets. Isolates of B. elizabethae have been made from Norway rats collected from alleys in urban Baltimore, 8 indicating that this organism is present in inner-city rat populations. Rats are observed and trapped more often in alleyways than occupied homes, 24 where they may be frequently encountered by IDUs. Given the high prevalence of antibodies to B. elizabethae among IDUs in East and Central Harlem, it is surprising that no isolates of this organism were obtained from 87 Norway rats collected from New York City. 8 However, these rats were trapped in the vicinity of Central Park, and the ecological conditions between Central Park and Central and East Harlem are considerably different. Furthermore, B. elizabethae infections in R. norvegicus may be highly focal. 8 Rat populations in inner cities may be effectively isolated by major streets or other barriers, and movement between blocks is minimal. 25 Attempts to isolate Bartonella species from rats collected in Harlem and other locations in New York City would be worthwhile. Rat infestations are common in many areas within New York City. 26 The association between prevalence of antibodies to B. elizabethae and sexual orientation is less clear. Presumably, this association reflects a behavioral characteristic that may be associated with sexual activity that places heterosexual individuals at greater risk for exposure to B. elizabethae. The role of sexual orientation and B. elizabethae infection deserves further exploration.
Antibodies to spotted fever group Rickettsia were detected in 9% of this population. Although Rocky Mountain spotted fever has been documented in New York City residents, 27 adsorption studies indicated that R. akari rather than R. rickettsii was the etiologic agent responsible for most if not all of the infections in Harlem IDUs. It was not altogether unexpected to find rickettsialpox infections among Harlem IDUs as clinical cases of rickettsialpox are occasionally diagnosed in New York City 28 where R. akari was first recognized. 29 The primary vector of R. akari is the house mouse mite (Allodermanyssus sanguineus). 30 Rodent populations, including house mice and Norway rats, can be large in decaying urban centers where IV drug use is prevalent and ample opportunity for contact with rodents and their ectoparasites exists. 24 Unfortunately, no information on rodent contact was available in the questionnaire associated with this cohort of IDUs. In Baltimore, the presence of antibodies to R. akari in a cohort of 630 IDUs was significantly associated with shooting gallery use, and it was speculated that contact with rodents was likely to occur under such conditions. 9 However, shooting gallery use was not significantly associated with reactivity to any antigen in the cohort from Harlem. It is likely that rickettsialpox routinely occurs in disadvantaged inner-city populations in many large American cities and is being underdiagnosed for a variety of reasons.
The number of seropositive samples detected for other antigens did not warrant statistical analysis. Low titers to R. prowazekii suggest that low-level exposure to typhus group rickettsiae may occur in this population, as Brill-Zinsser's disease (recurrent epidemic typhus) is unlikely to occur in a young non-immigrant population. No information on infestations of the body louse, the vector of R. prowazekii, was available for this cohort.
There were no antibodies detected to R. typhi. Two of 280 IDUs from inner-city Baltimore tested positive for R. typhi (both titers 128) (Comer JA, unpublished data). Together, these data suggest that murine typhus presently occurs at a very low frequency or does not exist in the IDU populations in these urban areas.
IDUs may serve as important sentinel populations for certain disease agents that may be only rarely diagnosed in the general population. In addition to needle sharing, which facilitates the spread of blood-borne pathogens, a constellation of other behavioral or environmental risk factors make IDUs more prone to exposure to certain zoonotic pathogens and their reservoir hosts or vectors. In addition, immune system impairment due to infectious agents, substance abuse, and nutritional deficiency may predispose these individuals to disease when exposure occurs. Studies in two urban locations now suggest that zoonotic, rodent-associated infections that may be associated with environmental factors are common among inner-city IDUs. Future studies that assess exposure to rodents and arthropods in the IDU environment in prospectively followed cohorts of inner-city populations will provide needed information on the disease burden and on the specific risks for infection with zoonotic agents in the inner-city environment.
